source
- JATT mastermind launches latest biotech-focused SPAC via $60M IPOJust two months after Someit Sidhu, M.D., succeeded in pairing off his second special purpose acquisition company (SPAC) with Talawar Therapeutics, the biotech entrepreneur is back at it again.Fierce Biotech · 5h ago↗ source
- Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its businessThis year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim.Fierce Biotech · 7h ago↗ source
- Spyre’s rheumatoid arthritis plan toppled by subpar TL1A dataPhase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis have fallen short of expectations, prompting the biotech to deprioritize monotherapy development in the indicat…